Voss Capital, LP

Holdings History for Rein Therapeutics, Inc. - Common Stock, $0.001 par value (RNTX)

Symbol: RNTX on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value
Latest Disclosed Shares Owned: 4,468,969 shares
Security Ownership %: 17%

Shares, Excluding Options vs Price

Value, Excluding Options

Voss Capital, LP ownership in Rein Therapeutics, Inc. Common Stock, $0.001 par value (RNTX)

13 Feb 2026 - Voss Capital, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,468,969 shares of Rein Therapeutics, Inc. Common Stock, $0.001 par value (RNTX). This represents 17% ownership of the company. In their previous filing dated 26 Sep 2025, Voss Capital, LP had reported owning 2,666,532 shares, indicating an increase of +68%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Voss Capital, LP	17%	+52%	$5,586,211	4,468,969	+1,802,437	+68%	$1.25	13G/A	31 Dec 2025	13 Feb 2026, 16:15
Voss Capital, LP	11%	+95%	$3,733,145	2,666,532	+1,388,676	+109%	$1.40	13G/A	24 Sep 2025	26 Sep 2025, 18:46
Voss Capital, LP	5.6%		$2,338,476	1,277,856			$1.83	13G	08 May 2025	14 May 2025, 20:26

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.26%	+0.1%	$4,923,004	4,243,969	+1,577,437	+59%	$1.16	Q4 2025
30 Sep 2025	0.18%	+0.08%	$3,053,179	2,666,532	+1,232,846	+86%	$1.14	Q3 2025
30 Jun 2025	0.14%	+0.04%	$2,007,160	1,433,686	+442,970	+45%	$1.40	Q2 2025
31 Mar 2025	0.13%	+0%	$1,753,567	990,716	+34,521		$1.77	Q1 2025
31 Dec 2024	0.16%	+0.16%	$2,199,249	956,195	+956,195	NEW	$2.30	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.